NGL Fine-Chem Q4 FY26: Revenue Surges 56% YoY to ₹145 Crore with ₹1.75 Final Dividend
NGL Fine-Chem reported Q4 FY26 revenue of ₹145 crore, surging 56% year-on-year driven by strong demand in pharmaceutical chemicals and API segments
TLDR
- ●NGL Fine-Chem Q4 revenue hit ₹145 crore, up 56% YoY on pharma chemical demand
- ●Board proposes ₹1.75 final dividend for FY26 on strong cash generation
- ●Operational efficiency and key segment demand drive healthy Q4 profitability
Editorial Self-Review·70/100Review tier
- Specific ₹145 crore revenue figure with 56% YoY growth
- Dividend amount (₹1.75) disclosed
- Single Tier 3 source
- No net profit figure or margin data
Why this matters
Coverage sentiment: Bullish (1 bullish · 0 neutral · 0 bearish)
NGL Fine-Chem's 56% revenue surge in pharma chemicals signals strong demand for active pharmaceutical ingredients (APIs) from Indian manufacturers, relevant to global generics supply chain investors tracking Indian pharma competitiveness.
What to watch
- • NGL Fine-Chem Q1 FY27 results — whether 56% revenue growth momentum continues into new fiscal year
- • India pharma API export data — whether sector-wide growth confirms NGL's company-level performance
Ripple effects
- • Indian specialty pharma sector — bullish as NGL's strong growth validates API demand recovery from global pharma restocking
AI-Synthesized news from multiple sources
This article was synthesized by AI from the source articles listed below, reviewed by a second-pass AI quality reviewer, and published by the market.news editorial system. How we do this · Editorial standards · Report an error
The Quick Take
- NGL Fine-Chem reported Q4 FY26 revenue of ₹145 crore, surging 56% year-on-year driven by strong demand in pharmaceutical chemicals and API segments
- The board proposed a final dividend of ₹1.75 per share for FY26, reflecting solid cash generation from the business
- Improved demand across key product segments and operational efficiency underpinned the company's healthy Q4 profitability growth
Synthesized from 1 source — full coverage, sentiment breakdown, and forward signals below.
Market Intelligence Panel
Sentiment
BullishCoverage
livesource covering this story
Live Price
NSE:NIFTY📊 Key Numbers
🌍 India / Asia Angle
NGL Fine-Chem's 56% revenue surge in pharma chemicals signals strong demand for active pharmaceutical ingredients (APIs) from Indian manufacturers, relevant to global generics supply chain investors tracking Indian pharma competitiveness.
🌊 Ripple Effects
- ▸Indian specialty pharma sector — bullish as NGL's strong growth validates API demand recovery from global pharma restocking
- ▸Chemical/API raw material suppliers — positive demand signal for specialty chemical inputs used in NGL's production
- ▸NGL Fine-Chem dividend investors — ₹1.75 final dividend announcement signals strong cash generation ability
🔭 What to Watch Next
PRO- ▸NGL Fine-Chem Q1 FY27 results — whether 56% revenue growth momentum continues into new fiscal year
- ▸India pharma API export data — whether sector-wide growth confirms NGL's company-level performance
- ▸Dividend ex-date and board approval timeline — key for income-focused investors to position ahead of dividend record date
Market news synthesis. Not financial advice. Sources cited above.
How the Story Spread
1 publisher covering this story
AI synthesis of every source listed below. Tier 1 = wire services (AP, Reuters via wire, Bloomberg, official central banks). Tier 2 = major financial publishers. Tier 3 = niche / specialist outlets. Click any card to read the original article.
Get the Daily Briefing
Pre-market analysis every morning at 6am ET. Free.
Was this article useful?
Anonymous · helps us tune the editorial system
More 🇮🇳 India Stories
India Pineapple Growers Face Price Crash and Labour Shortage as Kerala Association Urges Crop Pause
Kerala's pineapple growers are facing a simultaneous price crash and labour shortage, prompting the Keralam association to suggest farmers pause planting new crops
May 23, 2026
🇮🇳 IndiaRupee Swings 63 Paise to Settle at 95.73 as Rubio's Iran Diplomacy Remarks Ease Dollar Demand
The Indian rupee swung sharply on May 22, opening 6 paise lower at 96.26 against the US dollar before surging 63 paise to close at 95.73 — a strong intraday recovery
May 23, 2026
🇮🇳 IndiaTranscorp Q4 FY26: All-Time High Earnings, 30% Dividend, and RBI Payment Systems Access Secured
Transcorp delivered all-time high earnings for both Q4 FY26 and the full fiscal year 2026, marking the company's strongest profitability performance on record
May 23, 2026